Vertex Pharmaceuticals Insider Trades

VRTX

Vertex Pharmaceuticals (VRTX) is a global biopharmaceutical company renowned for developing transformative medicines for serious diseases, particularly in areas like cystic fibrosis, sickle cell disease, and beta thalassemia. The company's leadership includes key figures such as Executive Chairman Dr. Jeffrey Leiden and President and CEO Dr. Reshma Kewalramani. Tracking insider trading activity from Vertex Pharmaceuticals' executives and directors can offer insights into their perspectives on the company's future performance and ongoing advancements in its diverse pipeline of innovative therapies.

Trades Last 12 Months

VRTX Price

All Insider Trades for Vertex Pharmaceuticals

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bozic Carmen EVP And CMO
Holding Value $7.46M 15,933 shares
Last Trade
Jun 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$471k 1,020 shares
$462.17
$468.28
Bunnage Mark E. Evp, Chief Scientific Officer
Holding Value $3.41M 7,284 shares
Last Trade
May 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$15k 33 shares
$453.45
$468.28
Holding Value $2.31M 4,924 shares
Last Trade
May 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$135k 318 shares
$423.73
$468.28
Carney Lloyd Director
Holding Value $1.34M 2,866 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 2,866 shares
$424.45
$468.28
Liu Joy EVP And Chief Legal Officer
Holding Value $9.71M 20,729 shares
Last Trade
May 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$469k 1,104 shares
$425.02
$468.28
Holding Value $653k 1,394 shares
Last Trade
May 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$337k 796 shares
$423.92
$468.28
Mckenzie Diana Director
Holding Value $1.11M 2,378 shares
Last Trade
May 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$337k 796 shares
$423.92
$468.28
Upadhyay Suketu Director
Holding Value $730k 1,558 shares
Last Trade
May 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$337k 796 shares
$423.92
$468.28
Sachs Bruce I Director
Holding Value $1.34M 2,866 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 2,866 shares
$424.45
$468.28
Thornberry Nancy Director
Holding Value $1.17M 2,507 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$976k 2,303 shares
$423.92
$468.28
Garber Alan M Director
Holding Value $3.44M 7,344 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$808k 1,905 shares
$423.92
$468.28
Lagarde Michel Director
Holding Value $1.34M 2,866 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 2,866 shares
$424.45
$468.28
Mc Kechnie Duncan Evp, Chief Commercial Officer
Holding Value $5.85M 12,489 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.31M 2,633 shares
$498.42
$468.28
Kewalramani Reshma CEO & President
Holding Value $64.6M 137,878 shares
Last Trade
Feb 27, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$19.7M 40,000 shares
$493.48
$468.28
Ambrose Kristen SVP & Chief Accounting Officer
Holding Value $3.1M 6,624 shares
Last Trade
Feb 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$173k 357 shares
$483.36
$468.28
Biller Jonathan EVP And Chief Legal Officer
Holding Value $6.4M 13,659 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$460k 945 shares
$486.35
$468.28
Atkinson Edward Morrow Iii Evp, Chief Technical Ops. Off.
Holding Value $8.63M 18,432 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$325k 668 shares
$486.35
$468.28
Sachdev Amit EVP Chief Patient & Ext Af Off
Holding Value $26M 55,570 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$898k 1,846 shares
$486.35
$468.28
Tatsis Ourania Evp, Chief Reg. & Quality Off.
Holding Value $21.9M 46,763 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$126k 260 shares
$486.35
$468.28
Leiden Jeffrey M Executive Chairman
Holding Value $16.3M 34,797 shares
Last Trade
Feb 24, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.72M 3,547 shares
$485.11
$468.28

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up